EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Next-Generation GLP-1 Agonist Bioassays: Integrating Precision with Biological Relevance

Christine Graf, Julia Reuter, Sabrina Rüggeberg, Sebastian Mohr, Julia Petri, Sylvie Gelinas, Birgit Niederhaus iD, Ulrich Werner, Nina Strebe, Zeina El Zein, Dirk Usener

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Christine Graf und 10 weiteren Autor:innen. Beteiligte Einrichtung: CMC Bioanalytics, Sanofi R&D, 65926 Frankfurt, Germany. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Biological Assay. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-Like Peptide-1 (GLP-1) is an incretin family peptide hormone with significant therapeutic applications. This study evaluated multiple functional methodologies for assessing GLP-1 agonist biological activity, encompassing in vitro cell-based bioassays and in vivo systems. We developed and comparatively analyzed cell-based bioassays measuring distinct cellular signaling events, such as β-arrestin recruitment, cyclic adenosine monophosphate (cAMP) elevation, and calcium (Ca2+) mobilization. Each assay was systematically evaluated for robustness and quality control applicability. All assay systems demonstrated functionality independent of the cellular mechanism employed. Real-time Ca2+ flux measurements confirmed the cell-based assay endpoint data, while cross-verification analyses using the oral glucose tolerance test in mice confirmed the representativeness of the cAMP formats. Initial validation studies revealed inter-assay variations, leading to the selection of the cAMP HTRF assay as the preferred quality control methodology. Further assay refinement and subsequent validation studies confirmed the cAMP HTRF assay’s suitability for quality control applications. This methodology has been successfully implemented in routine release testing of a commercially available GLP-1 agonist.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1Biological AssayAnimalsCyclic AMPMiceHumansCalciumGlucose Tolerance Testbeta-ArrestinsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

GLP-1 agonistsHTRF assayassay-ready cellsbioassaycalcium releasecell cycle arrestin vivo cross-verificationmode of actionoral glucose tolerance test in micepotency

Substanzen

Glucagon-Like Peptide 1Cyclic AMPCalciumbeta-ArrestinsGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • CMC Bioanalytics, Sanofi R&D, 65926 Frankfurt, Germany.
  • MSAT Analytics, Sanofi M&S, 65926 Frankfurt, Germany.
  • Quality Control, FBC Quality, Sanofi M&S, 65926 Frankfurt, Germany.
  • Bioanalytical Solutions, Cerbaresearch, Laval, QC H7V 4A7, Canada.
  • MSAT Statistics, Sanofi M&S, 65926 Frankfurt, Germany.
  • Diabetes Division, Sanofi R&D, 65926 Frankfurt, Germany.

ORCID-Profile: Birgit Niederhaus

Zitieren

APA

Graf, C., Reuter, J., Rüggeberg, S., Mohr, S., Petri, J., Gelinas, S., Niederhaus, B., Werner, U., Strebe, N., Zein, Z. E., & Usener, D. (2026). Next-Generation GLP-1 Agonist Bioassays: Integrating Precision with Biological Relevance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188068

Vancouver

Graf C, Reuter J, Rüggeberg S, Mohr S, Petri J, Gelinas S, et al. Next-Generation GLP-1 Agonist Bioassays: Integrating Precision with Biological Relevance. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188068

BibTeX
@article{Graf2026,
  author = {Graf, Christine and Reuter, Julia and Rüggeberg, Sabrina and Mohr, Sebastian and Petri, Julia and Gelinas, Sylvie and Niederhaus, Birgit and Werner, Ulrich and Strebe, Nina and Zein, Zeina El and Usener, Dirk},
  title = {Next-Generation GLP-1 Agonist Bioassays: Integrating Precision with Biological Relevance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188068}
}
Kostenlos starten →